Mylan, the maker of EpiPen, says it will sell a generic version for $300 for a two-pack, a price that consumer advocates say is still too high. The device is used to treat severe allergic reactions. Daniel Acker/Bloomberg via Getty Images hide caption

toggle caption
Daniel Acker/Bloomberg via Getty Images

Maker Of EpiPen To Sell Generic Version For Half The Price

  • Download
  • <iframe src="https://www.npr.org/player/embed/491797051/491848114" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

In 2015, the Sandoz unit of drugmaker Novartis won Food and Drug Administration approval of a drug called Zarxio, which is similar to Amgen's Neupogen, a medicine that boosts the production of white blood cells. Sebastien Bozon/AFP/Getty Images hide caption

toggle caption
Sebastien Bozon/AFP/Getty Images

When your health insurer reclassifies a prescription drug you take from tier 1 to tier 2, it can sharply increase the portion of the drug's cost that you're expected to pay. Roberto Machado Noa/LightRocket via Getty Images hide caption

toggle caption
Roberto Machado Noa/LightRocket via Getty Images

The question of how pharmaceutical payments to doctors affect medical practice has been fraught. Hero Images/Getty Images hide caption

toggle caption
Hero Images/Getty Images

Drug-Company Payments Mirror Doctors' Brand-Name Prescribing

  • Download
  • <iframe src="https://www.npr.org/player/embed/470679452/470776709" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Katie Park/NPR

Cancer And Arthritis Drugs Drive Up Spending On Medicines

  • Download
  • <iframe src="https://www.npr.org/player/embed/470417680/470486343" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A nurse in 1938 checks the amount of insulin in a needle. For many decades, the only insulin available to people with diabetes came from the pancreases of cattle or pigs. Insulin from animals is still available outside the U.S. — and cheaper than a recombinant DNA version. Bettmann/Corbis hide caption

toggle caption
Bettmann/Corbis

Why Is Insulin So Expensive In The U.S.?

  • Download
  • <iframe src="https://www.npr.org/player/embed/393856788/393982160" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
iStockphoto.com

Big-Name Drugs Are Falling Off The 'Patent Cliff'

  • Download
  • <iframe src="https://www.npr.org/player/embed/141596137/141646202" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Laura Zakhar connects her son, Kevin, 15, to the "feedbag" that contains his nutrition. Lately, Zakhar has had trouble getting the calcium solution Kevin needs, in part because hospitals have been reserving limited supplies for patients who need it even more desperately than he does. Elizabeth Larkin for NPR hide caption

toggle caption
Elizabeth Larkin for NPR

Shortages Lead Doctors To Ration Critical Drugs

  • Download
  • <iframe src="https://www.npr.org/player/embed/140958404/141002440" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Big Pharma's Golden Age Leads To Generics Windfall

  • Download
  • <iframe src="https://www.npr.org/player/embed/136469996/136475110" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript